CITALOPRAM HYDROBROMIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71610-092 -
Package NDC
71610-092-15 -
Package NDC
71610-092-30 -
Package NDC
71610-092-45 -
Package NDC
71610-092-60 -
Application number
ANDA077534 -
SPL ID
d05f4e71-95f3-4f22-8b01-b21e5c19e0f2 -
SPL set ID
d05f4e71-95f3-4f22-8b01-b21e5c19e0f2 -
UNII
I1E9D14F36 -
RxCUI
200371
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- CITALOPRAM
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "CITALOPRAM HYDROBROMIDE",
"splId": "d05f4e71-95f3-4f22-8b01-b21e5c19e0f2",
"labels": [
{
"setId": "d05f4e71-95f3-4f22-8b01-b21e5c19e0f2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d05f4e71-95f3-4f22-8b01-b21e5c19e0f2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d05f4e71-95f3-4f22-8b01-b21e5c19e0f2"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "15 TABLET in 1 BOTTLE (71610-092-15)",
"package_ndc": "71610-092-15",
"identifierStatus": "well-formed",
"marketing_start_date": "20180626"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (71610-092-30)",
"package_ndc": "71610-092-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20180626"
},
{
"sample": false,
"description": "45 TABLET in 1 BOTTLE (71610-092-45)",
"package_ndc": "71610-092-45",
"identifierStatus": "well-formed",
"marketing_start_date": "20180626"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (71610-092-60)",
"package_ndc": "71610-092-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20180626"
}
],
"productId": "71610-092_d05f4e71-95f3-4f22-8b01-b21e5c19e0f2",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "71610-092",
"deaSchedule": null,
"genericName": "CITALOPRAM",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CITALOPRAM HYDROBROMIDE",
"strength": "20 mg/1"
}
],
"applicationNumber": "ANDA077534",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171110",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"unii": [
"I1E9D14F36"
],
"rxcui": [
"200371"
],
"spl_set_id": [
"d05f4e71-95f3-4f22-8b01-b21e5c19e0f2"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71610-092_d05f4e71-95f3-4f22-8b01-b21e5c19e0f2"